Sector ratings Alnylam Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 02:30:00 07/03/2026 am IST			5-day change	1st Jan Change
320.66 ^USD	+0.05%		-3.68%	-19.36%

06/03	Tenaya Therapeutics and Alnylam Pharmaceuticals Enter Research Collaboration Agreement	CI
05/03	Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI
ALNYLAM PHARMACEUTICALS, INC.	4.25TCr	AA
ELI LILLY AND COMPANY	88TCr	A
JOHNSON & JOHNSON	58TCr	BBB
ABBVIE INC.	41TCr	AA
ROCHE HOLDING AG	35TCr	AA
NOVARTIS AG	30TCr	AAA
ASTRAZENECA PLC	30TCr	A
MERCK & CO., INC.	29TCr	A
AMGEN INC.	20TCr	A
GILEAD SCIENCES, INC.	18TCr	AAA
NOVO NORDISK A/S	17TCr	A
PFIZER INC.	15TCr	BBB
BRISTOL-MYERS SQUIBB COMPANY	12TCr	A
VERTEX PHARMACEUTICALS INCORPORATED	12TCr	AA
GSK PLC	11TCr	AA
SANOFI	11TCr	A
CHUGAI PHARMACEUTICAL CO., LTD.	10TCr	AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	5.7TCr	AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	5.34TCr	AA
HALEON PLC	4.5TCr	AA
Average	22.83TCr	AA
Weighted average by Cap.		AA